Activity Description:

This educational series will focus on reviewing best practices for birthing hospitals providing care for perinatal patients affected by substance use disorders. Discussions regarding key topics including combating stigma, implementation of SUD/OUD treatment, integration of peer support services, and building strong referral networks to ensure continuation of care.

Target Audience: 

Colorado birthing hospitals participating in CPCQC Perinatal SUD QI programming - doctors, midwives, advances practice providers, nurses, social workers, pharmacists, case managers, directors, managers, quality improvement, data

Learning Objectives:

1. Identify the leading causes of maternal mortality in Colorado.

2. Utilization of evidence-based interventions to manage perinatal SUD/OUD.

3. Demonstrate knowledge of evidence-based interventions to reduce maternal overdose.

Moderator:

Rachel Duncan, PharmD, BCPS, BCCCP

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of HCA Healthcare Continental Division and Colorado Perinatal Care Quality Collaborative. HCA Healthcare Continental Division is accredited by the ACCME to provide continuing medical education for physicians 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.